葛兰素史克(GSK)的股价在周三上午的交易中大涨6.97%,引发了广泛关注。公司在周二晚间公布了2024年第四季度财报,业绩优于预期,这是推动股价上涨的主要因素。
财报显示,葛兰素史克2024年第四季度每股调整后收益为0.59美元,同比下降17.13%,但高于分析师预期的0.43美元。季度销售额为104.04亿美元,同比增长3.37%,也超出市场预期的95.79亿美元。公司业绩出色,在专业药品、疫苗和普通药品等多个领域均有良好表现。
此外,葛兰素史克对2025年的业绩前景也持乐观态度。公司预计2025年营业额以固定汇率计算将增长3%至5%,核心营业利润和核心每股收益也将分别增长6%至8%。其中,专业药品销售额预计将实现低双位数增长,普通药品销售保持基本稳定,但疫苗销售或略有下滑。但总体来看,该公司仍有望延续良好的增长态势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.